PRECISIONBIOLOGICS
Menu
↗
PRECISION BIOLOGICS / LOCATIONS

Orthopedic Biologics Distributor for Baltimore, MD Practices

Precision Biologics distributes Wharton's jelly allografts and exosome products to orthopedic practices and surgery centers operating under physician supervision across the Southeast region. Accounts open only for licensed professionals verified against an NPI number, and product selection decisions remain with the treating physician and counsel.

REGISTRY DATA / MD

Baltimore

NPPES registry listings, primary taxonomy, retrieved 2026-10-27

327
Orthopaedic Surgery
327
Source: NPPES NPI Registry ↗

Opening an NPI-verified account

A Baltimore orthopedic group or surgery center opens an account by providing an NPI number, which Precision Biologics checks against the public NPI Registry before activation. Multi-site groups can register each location separately so that lot traceability stays matched to the correct practice address and patient records.

Vendor qualification inside a surgery center

Surgery centers in this region typically run a new biologics supplier through a compliance or value-analysis committee before it reaches the purchasing stage. That review usually asks for the supplier's HCT/P processing description, its lot-release and sterility-testing documentation, and confirmation that the supplier will support record requests after the sale.

Precision Biologics supplies that documentation set directly; it does not take part in the clinic's internal formulary decision.

Cold-chain shipping to the Southeast region

Cryopreserved products are stored at -80 degrees C and ship overnight on dry ice in validated containers; lyophilized formats are shelf-stable and ship without cryogenic handling. Each lot carries a unique identifier, so a Baltimore practice's intake staff can log the shipment against its certificate of analysis and maintain traceability at the patient record level.

Confirming regulatory posture

Whether a given intended use for a Wharton's jelly product meets the minimal manipulation and homologous use criteria under 21 CFR 1271.10 is a determination for the clinic and its own counsel. Verify your practice's regulatory standing with the Maryland medical board and counsel before adding any product to formulary, and request documentation - certificate of analysis, donor eligibility summary, lot release record - for the specific lot under review.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.

FAQ

Frequently asked questions

Can a surgery center with multiple Baltimore locations use one account?+

Yes, or each location can register separately; either way, every account is verified against an NPI number before activation.

What should our compliance committee ask for before approving a new biologics vendor?+

Request the certificate of analysis, donor eligibility summary, and lot release record for the specific lot, along with the supplier's HCT/P processing description, then have your counsel confirm regulatory classification.

How are shipments kept cold in transit to Maryland?+

Cryopreserved products ship overnight on dry ice in validated containers and are stored at -80 degrees C beforehand; your practice should plan to move them into on-site cold storage as soon as they arrive.